SAGE Therapeutics's market cap is currently $439.59M. The company's EPS TTM is $-6.597; its P/E ratio is ―; SAGE Therapeutics is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $-0.99. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 41.24M	$ 86.45M	$ 7.69M	$ 6.31M	$ 1.11B
Gross Profit	$ 31.80M	$ 84.30M	$ 6.87M	$ 5.75M	$ 1.11B
Operating Income	$ -432.37M	$ -579.85M	$ -546.99M	$ -460.91M	$ 596.23M
EBITDA	$ -409.49M	$ -545.07M	$ -545.87M	$ -456.73M	$ 626.60M
Net Income	$ -400.67M	$ -541.49M	$ -503.27M	$ -450.83M	$ 606.07M
Balance Sheet
Cash & Short-Term Investments	$ 504.42M	$ 753.18M	$ 1.27B	$ 1.74B	$ 2.10B
Total Assets	$ 547.22M	$ 882.28M	$ 1.36B	$ 1.83B	$ 2.16B
Total Debt	$ 11.84M	$ 5.17M	$ 12.13M	$ 18.43M	$ 28.10M
Net Debt	$ -69.19M	$ -65.83M	$ -150.57M	$ -275.80M	$ -1.63B
Total Liabilities	$ 82.13M	$ 82.75M	$ 103.85M	$ 96.26M	$ 86.91M
Stockholders' Equity	$ 465.09M	$ 799.53M	$ 1.25B	$ 1.73B	$ 2.07B
Cash Flow
Free Cash Flow	$ -267.19M	$ -541.14M	$ -460.97M	$ -378.55M	$ 663.93M
Operating Cash Flow	$ -267.19M	$ -540.59M	$ -460.04M	$ -378.18M	$ 664.28M
Investing Cash Flow	$ 266.68M	$ 442.91M	$ 325.43M	$ -1.00B	$ 442.68M
Financing Cash Flow	$ 10.66M	$ 6.03M	$ 3.07M	$ 13.33M	$ 426.76M

Currency in USD

SAGE Therapeutics Earnings and Revenue History

Income Statement >

SAGE Therapeutics Debt to Assets

Balance Sheet >

SAGE Therapeutics Cash Flow

Cash Flow >

SAGE Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing